TriangleNCT01871727 · OUTCOME
Lead-In Part: Terminal Elimination Half-life (t1/2) of E7777
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- minutes
- Interval / dispersion
- Full Range
- Time frame
- Cycles 1, 3, 5 Day 1: Pre-dose up to 300 hours post-dose (Cycle length was 21 days)
What was measured
Participants were not available for analysis in 15 mcg/kg (Cycles 3 and 5), 6 mcg/kg (Cycle 5), 9 mcg/kg (Cycles 3 and 5), 12 mcg/kg (Cycle 3), hence no PK data was collected and analyzed for these doses and cycles.
Analysis population: Lead-in PK analysis set included all participants who received at least one dose of study drug and from whom at least one valid E7777 PK parameter was obtained. Here "overall number of participants analyzed" signifies participants who were evaluable for this outcome measure. Here "number analyzed" signifies participants who were evaluable for this outcome measure for given timepoints.
Groups in this outcome
Lead-In Part: E7777 6 mcg/kg
Participants were treated with E7777 6 mcg/kg by IV infusion over 60 minutes on 5 consecutive days in 21-day cycles for up to 8 cycles or disease progression or unacceptable toxicity in Lead-in part.
Lead-In Part: E7777 9 mcg/kg
Participants were treated with E7777 9 mcg/kg by IV infusion over 60 minute on 5 consecutive days during every 21-day cycles for up to 8 cycles or disease progression or unacceptable toxicity in Lead-In Part.
Lead-In Part: E7777 12 mcg/kg
Participants were treated with E7777 12 mcg/kg by IV infusion over 60 minutes on 5 consecutive days in 21-day cycles for up to 8 cycles or disease progression or unacceptable toxicity in Lead-in part.
Lead-In Part: E7777 15 mcg/kg
Participants were treated with E7777 15 mcg/kg by IV infusion over 60 minutes on 5 consecutive days in 21-day cycles for up to 8 cycles or disease progression or unacceptable toxicity in Lead-in part.
| Group | Source count |
|---|---|
| Lead-In Part: E7777 6 mcg/kg | 2 |
| Lead-In Part: E7777 9 mcg/kg | 4 |
| Lead-In Part: E7777 12 mcg/kg | 5 |
| Lead-In Part: E7777 15 mcg/kg | 2 |
Reported measurements
Cycle 1 Day 1
| Group | Source count |
|---|---|
| Lead-In Part: E7777 6 mcg/kg | 2 |
| Lead-In Part: E7777 9 mcg/kg | 4 |
| Lead-In Part: E7777 12 mcg/kg | 5 |
| Lead-In Part: E7777 15 mcg/kg | 2 |
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Lead-In Part: E7777 6 mcg/kg | 92.0 | Not reported | 74.5 | 109 | Not reported |
| Lead-In Part: E7777 9 mcg/kg | 116 | Not reported | 55.9 | 138 | Not reported |
| Lead-In Part: E7777 12 mcg/kg | 100 | Not reported | 47.9 | 120 | Not reported |
| Lead-In Part: E7777 15 mcg/kg | 100 | Not reported | 71.5 | 129 | Not reported |
Cycle 3 Day 1
| Group | Source count |
|---|---|
| Lead-In Part: E7777 6 mcg/kg | 1 |
| Lead-In Part: E7777 9 mcg/kg | 0 |
| Lead-In Part: E7777 12 mcg/kg | 0 |
| Lead-In Part: E7777 15 mcg/kg | 0 |
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Lead-In Part: E7777 6 mcg/kg | 39.6 | Not reported | 39.6 | 39.6 | Not reported |
Cycle 5 Day 1
| Group | Source count |
|---|---|
| Lead-In Part: E7777 6 mcg/kg | 0 |
| Lead-In Part: E7777 9 mcg/kg | 0 |
| Lead-In Part: E7777 12 mcg/kg | 1 |
| Lead-In Part: E7777 15 mcg/kg | 0 |
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Lead-In Part: E7777 12 mcg/kg | 20.5 | Not reported | 20.5 | 20.5 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 74.5
- upper Limit
- 109
- value
- 92.0
- group Id
- OG001
- lower Limit
- 55.9
- upper Limit
- 138
- value
- 116
- group Id
- OG002
- lower Limit
- 47.9
- upper Limit
- 120
- value
- 100
- group Id
- OG003
- lower Limit
- 71.5
- upper Limit
- 129
- value
- 100
- denoms
- counts
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 5
- group Id
- OG003
- value
- 2
- units
- Participants
- title
- Cycle 1 Day 1
- categories
- measurements
- group Id
- OG000
- lower Limit
- 39.6
- upper Limit
- 39.6
- value
- 39.6
- denoms
- counts
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 0
- group Id
- OG003
- value
- 0
- units
- Participants
- title
- Cycle 3 Day 1
- categories
- measurements
- group Id
- OG002
- lower Limit
- 20.5
- upper Limit
- 20.5
- value
- 20.5
- denoms
- counts
- group Id
- OG000
- value
- 0
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 1
- group Id
- OG003
- value
- 0
- units
- Participants
- title
- Cycle 5 Day 1
- denoms
- counts
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 5
- group Id
- OG003
- value
- 2
- units
- Participants
- description
- Participants were not available for analysis in 15 mcg/kg (Cycles 3 and 5), 6 mcg/kg (Cycle 5), 9 mcg/kg (Cycles 3 and 5), 12 mcg/kg (Cycle 3), hence no PK data was collected and analyzed for these doses and cycles.
- dispersion Type
- Full Range
- groups
- description
- Participants were treated with E7777 6 mcg/kg by IV infusion over 60 minutes on 5 consecutive days in 21-day cycles for up to 8 cycles or disease progression or unacceptable toxicity in Lead-in part.
- id
- OG000
- title
- Lead-In Part: E7777 6 mcg/kg
- description
- Participants were treated with E7777 9 mcg/kg by IV infusion over 60 minute on 5 consecutive days during every 21-day cycles for up to 8 cycles or disease progression or unacceptable toxicity in Lead-In Part.
- id
- OG001
- title
- Lead-In Part: E7777 9 mcg/kg
- description
- Participants were treated with E7777 12 mcg/kg by IV infusion over 60 minutes on 5 consecutive days in 21-day cycles for up to 8 cycles or disease progression or unacceptable toxicity in Lead-in part.
- id
- OG002
- title
- Lead-In Part: E7777 12 mcg/kg
- description
- Participants were treated with E7777 15 mcg/kg by IV infusion over 60 minutes on 5 consecutive days in 21-day cycles for up to 8 cycles or disease progression or unacceptable toxicity in Lead-in part.
- id
- OG003
- title
- Lead-In Part: E7777 15 mcg/kg
- param Type
- MEDIAN
- population Description
- Lead-in PK analysis set included all participants who received at least one dose of study drug and from whom at least one valid E7777 PK parameter was obtained. Here "overall number of participants analyzed" signifies participants who were evaluable for this outcome measure. Here "number analyzed" signifies participants who were evaluable for this outcome measure for given timepoints.
- reporting Status
- POSTED
- time Frame
- Cycles 1, 3, 5 Day 1: Pre-dose up to 300 hours post-dose (Cycle length was 21 days)
- title
- Lead-In Part: Terminal Elimination Half-life (t1/2) of E7777
- type
- SECONDARY
- unit Of Measure
- minutes
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice